Literature DB >> 10960880

The Caregiver Activity Survey (CAS): longitudinal validation of an instrument that measures time spent caregiving for individuals with Alzheimer's disease.

D B Marin1, M Dugue, J Schmeidler, J Santoro, J Neugroschl, G Zaklad, A Brickman, E Schnur, J Hoblyn, K L Davis.   

Abstract

Family members incur substantial financial costs during the course of caring for an individual with Alzheimer's disease. Much of this cost is associated with time spent in caregiving tasks, including supervision and communication with the patient, and assisting with activities of daily living. We have previously reported on the cross sectional reliability and validity of a scale that measures time spent caregiving, the Caregiver Activity Survey (CAS). This study extends our results to a longitudinal study of the validity of the instrument. Forty-four outpatients with Alzheimer's disease who lived with a primary caregiver were followed over a period of 1 year 6 months. At six month intervals, the patients were administered the Mini Mental State Exam (MMSE), Alzheimer's Disease Assessment Scale (ADAS), and the Physical Self Maintenance Scale (PSMS). Caregivers completed the CAS. Over time, the CAS correlated significantly with the MMSE (r=-0.58, p=0.000), ADAS cognitive subscale (r=0.56, p=0. 000) and PSMS (r=0.49, p=0.000). As patients declined, caregivers spent less time communicating with and more time supervising the patient. Excluding the communication item, time spent caregiving increased significantly over time. This prospective study longitudinally validates the CAS with Alzheimer's patients. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 10960880     DOI: 10.1002/1099-1166(200008)15:8<680::aid-gps180>3.0.co;2-7

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  5 in total

Review 1.  The economic impact of neuropsychiatric symptoms in Alzheimer's disease: can drugs ease the burden?

Authors:  Daniel L Murman; Christopher C Colenda
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 2.  Assessment, measures and approaches to easing caregiver burden in Alzheimer's disease.

Authors:  Karl Farcnik; Michelle S Persyko
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

3.  The economic burden of home care for children with HIV and other chronic illnesses.

Authors:  Leslie S Wilson; Judith Tedlie Moskowitz; Michael Acree; Melvin B Heyman; Paul Harmatz; Stephen J Ferrando; Susan Folkman
Journal:  Am J Public Health       Date:  2005-06-28       Impact factor: 9.308

Review 4.  Does pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease relieve caregiver burden?

Authors:  Karen Levy; Krista L Lanctôt; Shale B Farber; Abby Li; Nathan Herrmann
Journal:  Drugs Aging       Date:  2012-03-01       Impact factor: 3.923

5.  Clinical and Demographic Predictors of Adverse Outcomes in Caregivers of Patients with Dementia.

Authors:  Sun Min Lee; Yunhwan Lee; Seong Hye Choi; Tae Sung Lim; So Young Moon
Journal:  Dement Neurocogn Disord       Date:  2019-04-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.